Merck & Co., Inc.
MRK
$92.93
$1.481.62%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 56.68% | 19.44% | 656.03% | 4,589.59% | 163.63% |
| Total Depreciation and Amortization | 7.44% | 13.35% | 19.10% | 13.75% | 9.09% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -94.43% | 157.54% | -73.34% | -66.05% | -67.62% |
| Change in Net Operating Assets | -290.41% | -152.97% | -48.20% | -66.30% | 38.13% |
| Cash from Operations | -6.56% | 11.05% | 41.48% | 65.06% | 6.25% |
| Capital Expenditure | -17.29% | -7.59% | -3.28% | 12.71% | 14.89% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 99.95% | -348.66% | 70.77% | 65.98% | 66.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -97.34% | -124.76% | -131.87% | -114.85% | 647.37% |
| Cash from Investing | 36.12% | -176.82% | 40.11% | 45.08% | 60.73% |
| Total Debt Issued | 67.41% | -97.16% | -39.40% | -39.40% | -39.40% |
| Total Debt Repaid | -303.18% | -302.52% | -21.32% | 26.50% | 56.99% |
| Issuance of Common Stock | -66.67% | -72.25% | -40.11% | 41.60% | -55.47% |
| Repurchase of Common Stock | -257.11% | -179.38% | -78.01% | 2.97% | -26.97% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -4.75% | -5.08% | -5.28% | -5.31% | -5.42% |
| Other Financing Activities | 11.71% | -5.47% | -8.92% | -13.41% | 15.27% |
| Cash from Financing | -54.47% | -81.77% | -79.05% | -46.20% | -52.17% |
| Foreign Exchange rate Adjustments | -33.46% | 339.27% | 100.50% | -1,373.91% | 28.08% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -40.65% | -158.29% | 174.39% | 209.29% | 330.61% |